$0.0238
-0.001120 (-4.49%)24H
Bio Protocol price, last 12 months
0.10240.02380.0161
Bio Protocol market data
- 24H High
- $0.0249
- 24H Low
- $0.0235
- 24H Volume
- 35.16M BIO
- All Time High
- $1.48
- All Time Low
- $0.0157
- Correlation with BTC
- 0.03
- Return on Investment
- -20.60%
- Market Cap
- $60.02M
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.The BIO token is the key the DeSci economy. It is a governance token that lets holders signal support for specific BioDAOs and gain whitelisted access to their initial funding rounds.
Cryptocurrencies similar to Bio Protocol
Bio Protocol whitepaper summary
BIO Protocol is a specialized platform that helps science-focused communities (BioDAOs) collaborate and secure funding efficiently.
It functions like a scientific research marketplace where people can support and invest in promising medical and biotech projects from their early stages.
The platform aims to revolutionize scientific research by creating a seamless connection between researchers, investors, and community members, making breakthrough discoveries more accessible.
The BIO Protocol operates through five key features designed to streamline scientific research and funding processes.
The curation system works like a community-driven selection committee.
When you hold BIO tokens, you become part of this committee, helping evaluate and choose which scientific projects should join the network.
This ensures only high-quality projects receive support and funding.
The funding system provides early access benefits to active participants.
Those who help select projects during the curation phase receive priority investment opportunities.
This creates a fair and inclusive environment where individual investors can participate alongside traditional venture capital firms.
The protocol's liquidity management system automates the complex task of maintaining steady funding flows.
This innovative approach allows research teams to focus entirely on their scientific work while the protocol handles financial operations.
The system includes various trading pairs and builds protocol-owned liquidity, ensuring stable market operations.
The Bio/acc rewards system incentivizes progress and innovation.
Projects receive bonus rewards for achieving significant milestones, such as starting clinical trials, developing new treatments, or securing patents.
This motivates research teams and helps accelerate scientific breakthroughs.
The meta-governance feature empowers BIO token holders to participate in decision-making across multiple scientific projects.
This creates an interconnected network where community members can help guide various research initiatives while maintaining their focus on advancing scientific discovery.
The BIO token functions as a multi-purpose access key to the scientific community, offering various benefits and opportunities.
Token holders gain several important privileges:
They can participate in selecting new research projects.
They receive priority access to investment opportunities and IP rights.
They may qualify for discounts on products and services developed by network projects.
The protocol generates revenue through two primary channels.
First, it receives a 6.9% token allocation from each new scientific project it launches, in exchange for providing a $100,000 grant.
This creates a growing portfolio of valuable scientific assets.
Second, the protocol earns fees from managing token trading and liquidity pools.
This automated system ensures smooth market operations while generating sustainable revenue.
The Bio/acc rewards program allocates 4% of total BIO tokens to incentivize network growth and scientific achievement.
These rewards are distributed when projects reach important milestones, encouraging continuous progress.
All revenue streams flow into the BIO treasury, which reinvests in new projects and platform development.
This creates a self-sustaining cycle where successful projects contribute to funding future scientific innovations.
BIO Protocol continues to expand its network of scientific communities, building on significant early successes.
VitaDAO, one of their flagship projects, has already funded over $5 million in longevity research and secured a partnership with Pfizer Ventures.
This demonstrates the protocol's ability to connect innovative research with major industry players.
The second cohort of projects includes groundbreaking initiatives like Long COVID Labs, focusing on treating Long COVID patients, and Quantum Biology DAO, developing advanced microscopes for biological research.
These projects showcase the protocol's versatility across different scientific domains.
Future development focuses on standardizing frameworks for new BioDAOs, improving tokenomics models, and expanding data and product offerings.
The goal is to create deeper, more liquid markets for scientific IP while making it easier for new projects to join and succeed.
The protocol aims to become the leading platform for decentralized science funding, continuously adding new projects and expanding into different areas of scientific research.
Bio Protocol FAQ
Bio Protocol (BIO) is trading at $0.0238, down 4.49% over the last 24 hours.
The market cap of Bio Protocol is $60.02M, ranking #264 among cryptocurrencies.
Our model's year-end 2026 target for BIO is $0.0572.
Our model's 2030 target for BIO is $0.004455.
On the daily chart BIO currently shows 4 buy signals and 4 sell signals. This is not investment advice.
The all-time high of BIO is $1.48.
This page is for informational purposes only and is not investment advice. Cryptocurrency prices are highly volatile.






